vs

Side-by-side financial comparison of FTC Solar, Inc. (FTCI) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $32.9M, roughly 1.4× FTC Solar, Inc.). PACIFIC BIOSCIENCES OF CALIFORNIA, INC. runs the higher net margin — -90.4% vs -110.7%, a 20.3% gap on every dollar of revenue. On growth, FTC Solar, Inc. posted the faster year-over-year revenue change (148.9% vs 13.8%). FTC Solar, Inc. produced more free cash flow last quarter ($-8.4M vs $-19.9M). Over the past eight quarters, FTC Solar, Inc.'s revenue compounded faster (61.6% CAGR vs 7.3%).

FTC Solar, Inc. is a leading global provider of advanced solar tracker systems, associated components, and supporting software for solar projects. It serves utility-scale, commercial, and industrial solar segments across key global markets, helping customers boost energy generation efficiency and lower overall project costs.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

FTCI vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.4× larger
PACB
$44.6M
$32.9M
FTCI
Growing faster (revenue YoY)
FTCI
FTCI
+135.1% gap
FTCI
148.9%
13.8%
PACB
Higher net margin
PACB
PACB
20.3% more per $
PACB
-90.4%
-110.7%
FTCI
More free cash flow
FTCI
FTCI
$11.5M more FCF
FTCI
$-8.4M
$-19.9M
PACB
Faster 2-yr revenue CAGR
FTCI
FTCI
Annualised
FTCI
61.6%
7.3%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FTCI
FTCI
PACB
PACB
Revenue
$32.9M
$44.6M
Net Profit
$-36.4M
$-40.4M
Gross Margin
14.9%
37.1%
Operating Margin
-17.2%
-92.3%
Net Margin
-110.7%
-90.4%
Revenue YoY
148.9%
13.8%
Net Profit YoY
-197.4%
-1802.7%
EPS (diluted)
$-2.31
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FTCI
FTCI
PACB
PACB
Q4 25
$32.9M
$44.6M
Q3 25
$26.0M
$38.4M
Q2 25
$20.0M
$39.8M
Q1 25
$20.8M
$37.2M
Q4 24
$13.2M
$39.2M
Q3 24
$10.1M
$40.0M
Q2 24
$11.4M
$36.0M
Q1 24
$12.6M
$38.8M
Net Profit
FTCI
FTCI
PACB
PACB
Q4 25
$-36.4M
$-40.4M
Q3 25
$-23.9M
$-38.0M
Q2 25
$-15.4M
$-41.9M
Q1 25
$-3.8M
$-426.1M
Q4 24
$-12.2M
$2.4M
Q3 24
$-15.4M
$-60.7M
Q2 24
$-12.2M
$-173.3M
Q1 24
$-8.8M
$-78.2M
Gross Margin
FTCI
FTCI
PACB
PACB
Q4 25
14.9%
37.1%
Q3 25
6.1%
41.4%
Q2 25
-19.6%
36.9%
Q1 25
-16.6%
-3.7%
Q4 24
-29.1%
25.6%
Q3 24
-42.5%
25.0%
Q2 24
-20.5%
16.5%
Q1 24
-16.7%
29.1%
Operating Margin
FTCI
FTCI
PACB
PACB
Q4 25
-17.2%
-92.3%
Q3 25
-29.6%
-101.1%
Q2 25
-57.5%
-112.8%
Q1 25
-50.8%
-1154.5%
Q4 24
-101.7%
-390.1%
Q3 24
-147.8%
-160.3%
Q2 24
-104.3%
-488.3%
Q1 24
-99.3%
-209.6%
Net Margin
FTCI
FTCI
PACB
PACB
Q4 25
-110.7%
-90.4%
Q3 25
-92.0%
-98.9%
Q2 25
-77.2%
-105.4%
Q1 25
-18.4%
-1146.8%
Q4 24
-92.7%
6.0%
Q3 24
-151.5%
-151.9%
Q2 24
-107.1%
-481.3%
Q1 24
-69.7%
-201.4%
EPS (diluted)
FTCI
FTCI
PACB
PACB
Q4 25
$-2.31
$-0.11
Q3 25
$-1.61
$-0.13
Q2 25
$-1.18
$-0.14
Q1 25
$-0.58
$-1.44
Q4 24
$-0.95
$-0.44
Q3 24
$-1.21
$-0.22
Q2 24
$-0.97
$-0.64
Q1 24
$-0.70
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FTCI
FTCI
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$21.1M
$279.5M
Total DebtLower is stronger
$9.9M
Stockholders' EquityBook value
$-43.0M
$5.3M
Total Assets
$111.8M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FTCI
FTCI
PACB
PACB
Q4 25
$21.1M
$279.5M
Q3 25
$24.4M
$298.7M
Q2 25
$3.5M
$314.7M
Q1 25
$5.9M
$343.1M
Q4 24
$11.2M
$389.9M
Q3 24
$8.3M
$471.1M
Q2 24
$10.8M
$509.8M
Q1 24
$14.0M
$561.9M
Total Debt
FTCI
FTCI
PACB
PACB
Q4 25
$9.9M
Q3 25
$16.6M
Q2 25
$10.9M
Q1 25
$10.2M
Q4 24
$9.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FTCI
FTCI
PACB
PACB
Q4 25
$-43.0M
$5.3M
Q3 25
$-13.7M
$36.1M
Q2 25
$9.0M
$61.5M
Q1 25
$15.5M
$91.6M
Q4 24
$19.0M
$506.6M
Q3 24
$30.4M
$453.1M
Q2 24
$44.2M
$492.7M
Q1 24
$55.2M
$649.0M
Total Assets
FTCI
FTCI
PACB
PACB
Q4 25
$111.8M
$784.1M
Q3 25
$111.5M
$803.2M
Q2 25
$83.0M
$825.5M
Q1 25
$84.1M
$860.8M
Q4 24
$89.9M
$1.3B
Q3 24
$91.7M
$1.5B
Q2 24
$100.3M
$1.5B
Q1 24
$115.0M
$1.7B
Debt / Equity
FTCI
FTCI
PACB
PACB
Q4 25
Q3 25
Q2 25
1.20×
Q1 25
0.65×
Q4 24
0.50×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FTCI
FTCI
PACB
PACB
Operating Cash FlowLast quarter
$-8.0M
$-19.1M
Free Cash FlowOCF − Capex
$-8.4M
$-19.9M
FCF MarginFCF / Revenue
-25.7%
-44.6%
Capex IntensityCapex / Revenue
1.3%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-34.6M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FTCI
FTCI
PACB
PACB
Q4 25
$-8.0M
$-19.1M
Q3 25
$-14.6M
$-18.7M
Q2 25
$-2.3M
$-29.4M
Q1 25
$-8.5M
$-44.1M
Q4 24
$-16.7M
$-30.6M
Q3 24
$-2.4M
$-45.5M
Q2 24
$-3.8M
$-54.3M
Q1 24
$-11.9M
$-75.7M
Free Cash Flow
FTCI
FTCI
PACB
PACB
Q4 25
$-8.4M
$-19.9M
Q3 25
$-15.1M
$-18.8M
Q2 25
$-2.5M
$-29.9M
Q1 25
$-8.6M
$-45.4M
Q4 24
$-17.0M
$-32.3M
Q3 24
$-2.6M
$-46.3M
Q2 24
$-4.5M
$-55.7M
Q1 24
$-12.3M
$-79.6M
FCF Margin
FTCI
FTCI
PACB
PACB
Q4 25
-25.7%
-44.6%
Q3 25
-57.9%
-48.9%
Q2 25
-12.4%
-75.3%
Q1 25
-41.2%
-122.3%
Q4 24
-128.6%
-82.3%
Q3 24
-25.6%
-115.7%
Q2 24
-39.2%
-154.8%
Q1 24
-97.6%
-205.0%
Capex Intensity
FTCI
FTCI
PACB
PACB
Q4 25
1.3%
1.9%
Q3 25
1.7%
0.2%
Q2 25
0.9%
1.4%
Q1 25
0.4%
3.7%
Q4 24
2.2%
4.1%
Q3 24
2.2%
2.0%
Q2 24
6.1%
4.1%
Q1 24
3.4%
10.0%
Cash Conversion
FTCI
FTCI
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FTCI
FTCI

Products$26.2M80%
Services$6.7M20%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons